Delivery Order SPE2DB22D2214-SPE2DB24FS5DY
- Not listed
- This federal contract award, with an ID of SPE2DB22D1106 and SPE2DB24FDTZ6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,292.87 firm fixed-price delivery order covers the supply of COLACE 100 MG CAPSULE 60S to support military healthcare programs. The contract has an ultimate completion date of January 8, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds two significant Indefinite Delivery Contracts...
- This is a delivery order awarded by the U.S. Department of Defense's Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of a range of pharmaceutical products and medical supplies. The $14,004.72 firm-fixed-price contract has a completion date of June 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of a variety of pharmaceutical products and medical supplies. The $7,357.18 firm fixed-price delivery order does not utilize any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded by the U.S. Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,142.04 firm fixed-price contract is for the provision of various pharmaceutical products, medical supplies, and equipment to support military healthcare programs. The contract has an ultimate completion date of January 22, 2024. Amerisourcebergen holds a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,870.68 firm fixed price delivery order contract is for the supply of pharmaceutical products and medical supplies to support federal medical procurement needs, particularly for military and veteran healthcare systems. The contract is not set aside and allows for multiple delivery orders across different therapeutic...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $44,556.12 delivery order contract is for the supply of a wide range of pharmaceutical products and medical supplies, including prescription medications, medical devices, specialty pharmaceuticals, and other healthcare-related items. The contract is a firm fixed-price agreement with a performance period extending...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of a variety of medical and pharmaceutical products. The contract, valued at $784,784.64, has a firm fixed price and an ultimate completion date of March 25, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,640.27 Firm Fixed Price Delivery Order contract has an ultimate completion date of May 9, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,124.64 firm fixed-price contract is for the supply of various pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. The contract has an...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,140.36, is a Firm Fixed Price Delivery Order with an ultimate completion date of June 17, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB24FS5DYDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,368.12 firm fixed-price delivery order is for the supply of COLACE 100 MG CAPSULE 60S, a pharmaceutical product. The contract has an ultimate completion date of June 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order appears to be part of that larger IDC. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 6/3/24 |